Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII.
Koyama
Takatoshi
T
Department of Hematology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan. koyama.lmg@tmd.ac.jp
Nagao
Toshikage
T
Tsunozaki
Hidefumi
H
Arai
Morio
M
Miura
Osamu
O
D001323:Autoantibodies / Q000097:blood; D019468:Disease Management; D004359:Drug Therapy, Combination; D005167:Factor VII / Q000008:administration & dosage*; D005169:Factor VIII / Q000008:administration & dosage*; D015942:Factor VIIa; D006406:Hematoma / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D006467:Hemophilia A / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010537:Peritoneum; D011994:Recombinant Proteins / Q000008:administration & dosage; D016896:Treatment Outcome
D001323:Autoantibodies; D011994:Recombinant Proteins; C078147:F8 protein, human; D005167:Factor VII; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa